Toronto-Dominion Bank vs Tilray Brands Inc — how do they compare? Toronto-Dominion Bank trades at $121.35 (market cap $200.48B), while Tilray Brands Inc trades at $4.81 (market cap $649.42M). The key difference: Toronto-Dominion Bank is far larger — about 308.7× Tilray Brands Inc's market cap, and Toronto-Dominion Bank pays a 2.63% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| TD | TLRY | |
|---|---|---|
Market Cap | $200.48B | $649.42M |
Sector | Financials | Health |
52-Week High | $124.80 | $21.00 |
52-Week Low | $72.85 | $3.88 |
Dividend Yield | 2.63% | — |
Enterprise Value | — | $816.55M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TLRY trades at $4.57, up 2.93% with a bullish technical signal, though recent earnings misses and negative profitability metrics highlight fundamental challenges. The company reported record fiscal 2026 revenue of $915 million but continues to post significant net losses. Analyst sentiment is mixed with 25% buy ratings, while technical indicators show RSI near overbought levels with key support at $4.
Outlook remains cautious due to persistent losses and high valuation multiples, though revenue growth and diversification into beverages offer potential upside. Key risks include execution challenges, cannabis regulatory uncertainty, and competitive pressures in the consumer goods space.
Trailing returns across standard periods
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →